Home/Filings/4/0001181431-06-002063
4//SEC Filing

BIO LOGIC SYSTEMS CORP 4

Accession 0001181431-06-002063

CIK 0000355007operating

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 8:32 PM ET

Size

39.5 KB

Accession

0001181431-06-002063

Insider Transaction Report

Form 4
Period: 2006-01-05
Transactions
  • Disposition to Issuer

    Common Stock, $0.01 par value

    2006-01-0525,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2006-01-05$5.60/sh3,750$21,0120 total
    Exercise: $3.17Exp: 2009-08-19Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2006-01-05$5.73/sh3,000$17,1850 total
    Exercise: $3.04Exp: 2007-08-12Common Stock (3,000 underlying)
Footnotes (15)
  • [F1]Disposed of pursuant to the merger agreement among Issuer, Natus Medical Incorporated and Summer Acquisition Corporation, in which each share of common stock of the Issuer was exchanged for $8.77 in cash, without interest, on the effective date of the merger.
  • [F10]This option, which provided for vesting in four equal annual installments beginning August 22, 2003, was cancelled in the merger in exchange for a cash payment of $22,137.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($2.8667) and the per share merger consideration ($8.77).
  • [F11]This option, which provided for vesting in four equal annual installments beginning March 3, 2004, was cancelled in the merger in exchange for a cash payment of $20,387.63, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.3333) and the per share merger consideration ($8.77).
  • [F12]This option, which provided for vesting in four equal annual installments beginning August 25, 2004, was cancelled in the merger in exchange for a cash payment of $20,562.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.2867) and the per share merger consideration ($8.77).
  • [F13]This option which provided for vesting in four equal annual installments beginning March 1, 2005, was cancelled in the merger in exchange for a cash payment of $18,012.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.9667)and the per share merger consideration ($8.77).
  • [F14]This option, which provided for vesting in four equal annual installments beginning July 22, 2005, was cancelled in the merger in exchange for a cash payment of $18,262.50 representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.90) and the per share merger consideration ($8.77).
  • [F15]This option, which provided for vesting in four equal annual installments to begin on March 1, 2006, was cancelled in the merger in exchange for a cash payment of $8,962.50, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($6.38) and the per share merger consideration ($8.77).
  • [F2]This option, which provided for vesting in four equal annual installments beginning August 12, 1998, was cancelled in the merger in exchange for a cash payment of $17,184.90, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.0147) and the per share merger consideration ($8.77).
  • [F3]This option, which provided for vesting in four equal annual installments beginning August 19, 1999, was cancelled in the merger in exchange for a cash payment of $20,184.00, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($2.0420) and the per share merger consideration ($8.77).
  • [F4]This option, which provided for vesting in four equal annual installments beginning October 30, 1999, was cancelled in the merger in exchange for a cash payment of $21,183.90, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($1.7087) and the per share merger consideration ($8.77).
  • [F5]This option, which provided for vesting in four equal annual installments beginning August 19, 2000, was cancelled in the merger in exchange for a cash payment of $21,012.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.1667) and the per share merger consideration ($8.77).
  • [F6]This option, which provided for vesting in four equal annual installments beginning August 17, 2001, was cancelled in the merger in exchange for a cash payment of $20,074.88, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.4167) and the per share merger consideration ($8.77).
  • [F7]This option, which provided for vesting in four equal annual installments beginning March 1, 2002, was cancelled in the merger in exchange for a cash payment of $24,762.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($2.1667) and the per share merger consideration ($8.77).
  • [F8]This option, which provided for vesting in four equal annual installments beginning August 23, 2002, was cancelled in the merger in exchange for a cash payment of $20,212.50, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.38) and the per share merger consideration ($8.77).
  • [F9]This option, which provided for vesting in four equal annual installments beginning March 1, 2003, was cancelled in the merger in exchange for a cash payment of $20,262.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.3667) and the per share merger consideration ($8.77).

Issuer

BIO LOGIC SYSTEMS CORP

CIK 0000355007

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000355007

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:32 PM ET
Size
39.5 KB